Business
iFabric Corp Announces Antiviral and Antibacterial Textile Treatment Is Effective Against COVID-19
Markham, Ontario--(Newsfile Corp. - May 11, 2020) - iFabric Corp. (TSX: IFA) ("iFabric" or the...
About this update from Ifabric Corp.
[{"type":"text","content":"iFabric Corp Announces Antiviral and Antibacterial Textile Treatment Is Effective Against COVID-19Markham, Ontario--(Newsfile Corp. - May 11, 2020) - iFabric Corp. (TSX: IFA) (\"iFabric\" or the \"Company\"), today provides details of its test results about the efficacy of fabrics treated with the Company's proprietary PROTX2 technology for inactivating the SARS-CoV-2 virus, which is the cause of COVID-19 disease.iFabric advises that efficacy testing of PROTX2 treated fabric against the SARS-CoV-2 virus was carried out by an internationally recognized, independent laboratory to establish its ability to inactivate the virus at time points of 10 minutes, 1 hour, 6 hours, and 24 hours. The laboratory reported that the treated fabrics demonstrated a greater than 99.9% reduction in active viral loads on the tested fabrics at each of the four time points. This represents a more than 1,000-fold reduction in active viral load when compared to untreated fabric. \"Motivated by the global need for protection of front-line workers and civilians alike, we are extremely excited to answer the call and bring forward a new weapon in the battle against the COVID-19 pandemic,\" stated Hylton Karon, President and CEO of iFabric. \"I believe this will be a game changer for iFabric and we will be distributing a number of PROTX2 treated products for medical, industrial, and consumer uses. The necessary emergency approvals from the United States Environmental Protection Agency (EPA) and Food and Drug Administration (FDA), and Health Canada are already in progress. The inclusion of this technology in products like PPE's (personal protective equipment) will provide a much-needed additional level of protection for current front-line workers. As we prepare to re-open our economies, we see this technology in many applications, not only in the medical market, but in everyday apparel for added protection,\" concluded Hylton Karon. About iFabric Corp. Headquartered in Markham, Ontario, iFabric Corp www.ifabriccorp.com is listed on the TSX and currently has 26.2 million shares issued and outstanding. Through its wholly-owned subsidiaries, Intelligent Fabric Technologies (North America) Inc. (\"IFTNA\") and Coconut Grove Pads Inc. (\"Coconut Grove\"), the Company offers a variety of products and services in both of its strategic divisions: IFTNA is focused on pe...